INTRODUCTION AND OBJECTIVES: The current evaluation of nephrectomy specimens centers on the pathological diagnosis, grade, and stage of the neoplasm.The evaluation of the non-neoplastic renal parenchyma is often overlooked. The remnant renal parenchyma can suffer the long-term effects of comorbidities, compromising functional outcomes. These changes can be assessed by histopathological analysis of non-neoplastic tissue of the nephrectomy specimen and can be used to predict the extent of future renal function compromise. In this study, we aim to evaluate changes in the non-neoplastic renal parenchyma in patients who were submitted to radical nephrectomy, as well as demographic and clinical parameters as predictors of decrease in renal function and development of new-onset CKD after surgery.
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METHODS: Data were extracted from 222 patients who underwent radical nephrectomy. The MDRD formula was used. The study end point was development of CKD, defined as an estimated glomerular filtration rate (eGFR) of less than 60 mL/min/1.73 m2. A renal pathologist assessed three histologic features in the non-neoplastic parenchyma, namely global glomerulosclerosis (GS), arteriosclerosis (AS), and interstitial fibrosis (IF). For GS assessment, the percent of affected glomeruli was determined. AS was graded and divided into three groups, namely 1d0%-25%, 2d26%-50%, and 3dgreater than 50%. IF was evaluated as absent or present.A nomogram was created to predict CKD following radical nephrectomy.
RESULTS: After a mean follow-up of 49.06 months, the mean eGFR rate decrease was 26.5% after radical nephrectomy. Almost half of the patients (53.8%) developed CKD. For each 2.5% increase in GS, each point increase in Charlson comorbidity index, and each 10year increase in patient's age, the eGFR decreased 28%, 33%, and 39%, respectively. In a univariate analysis, age, CCI, GS, AS, IF, hypertension, and DM were associated with new-onset CKD after radical nephrectomy. After multivariate logistic regression, CCI, GS, and baseline eGFR were associated with new-onset CKD after radical nephrectomy.
CONCLUSIONS: Histopathological evaluation of nonneoplastic renal parenchyma in patients who undergo radical nephrectomy can be used to predict the development of new-onset CKD. INTRODUCTION AND OBJECTIVES: Proteinuria reflects structural damage to glomeruli and/or renal tubules and is considered an important prognostic indicator of chronic kidney disease (CKD) and possibly acute kidney injury (AKI). We examined the significance of preoperative proteinuria on postoperative kidney function after robotic partial nephrectomy (RPN).
Source of
METHODS: We retrospectively reviewed 1121 consecutive RPN cases at a single academic center from 2006 to 2016. Patients without pre-existing CKD (eGFR60 mL/min/1.73m2) who had a urinalysis within 1-month prior to RPN were included. The cohort was categorized by the presence or absence of preoperative proteinuria (30 mg/dL), and groups were compared in terms of clinical and functional outcomes. The incidence of AKI was assessed using RIFLE criteria. Univariate and multivariable models were used to identify predictors of postoperative AKI.
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